Fig. 3.
Targeting PI3K/AKT/mTOR pathway by CRISPR/Cas9 in prostate cancer. Modification of expression of these targets has led to reduction of prostate cancer cell proliferation. Figure was depicted using BioRender
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.